Understand the key differences between melanoma and head & neck cancer clinical trials and research opportunities
Skin cancer with ~16,000 new UK cases annually. Immunotherapy and targeted therapy (BRAF/MEK) have transformed outcomes with active trial programmes.
Affects ~12,000 people in the UK annually. HPV-related oropharyngeal cancers have better prognosis. Trials focus on de-escalation strategies and immunotherapy.
Melanoma is a flagship for immunotherapy trials. Head and neck cancer trials are more diverse, covering surgical, radiation, and systemic approaches.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.